Hepatitis delta virus: The molecular basis of laboratory diagnosis

Critical Reviews in Clinical Laboratory Sciences

Volumn 37, Issue 1, 2000, Pages 45-92

  Modahl, Lucy E ^b   Michael M C, Lai ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

Hepatitis B virus; Hepatitis delta antigen; Liver transplantation; RT PCR; Serology; Viral replication

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS ANTIBODY; HEPATITIS DELTA ANTIGEN; HEPATITIS VACCINE; RIBOZYME; VIRUS RNA;

DELTA AGENT HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER TRANSPLANTATION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA HYBRIDIZATION; VACCINATION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS REPLICATION;

DELTA VIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; SATELLITE VIRUSES;

EID: 0034121584     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360091174178     Document Type: Review

References (203)

1. 1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997-1003.
2. 2. Rizzetto M, Hoyer B, Canese MG, et al. Delta agent: association of δ antigen with hepatitis B surface antigen and RNA in serum of δ-infected chimpanzees. Proc Natl Acad Sci USA 1980; 77: 6124-8.
3. 3. Rizzetto M, Purcell RH Gerin JL. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1980; 1: 1215-8.
4. 4. Ponzetto A, Forzani B, Parravicini PP, et al. Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol 1985; 1: 257-63.
5. 5. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26: 20-4.
6. 6. Huo TI, Wu JC, Lin RY, et al. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 1997; 12: 747-51.
7. 7. Hadler SC, de Monzon MA, Rivero D, et al. Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am J Epidemiol 1992; 136: 1507-16.
8. 8. Diener TO, Pruisner SB. Viroids and prions. In: K Maramorosch and JJ McKelvey, eds. Subviral pathogens of plants and animals. Pp. 3-18. Orlando: Academic, 1985.
9. 9. Murphy FA. Virus taxonomy: sixth report of the international committee on taxonomy of viruses. Pp. 493-4. Wien; New York: Springer-Verlag, 1995.
10. 10. Bonino F, Hoyer B, Shih JWK, et al. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immunity 1984; 43: 1000-5.
11. 11. Wang CJ, Chen PJ, Wu JC, et al. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol 1991; 65: 6630-6.
12. 12. Ryu WS, Netter HJ, Bayer M, et al. Ribonucleoprotein complexes of hepatitis delta virus. J Virol 1993; 67: 3281-7.
13. 13. Bonino F, Heermann KH, Rizzetto M, et al. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol 1986; 58: 945-50.
14. 14. Bergmann KF, Gerin JL. Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis 1986; 154: 702-6.
15. 15. Pohl C, Baroudy BM, Bergmann KF, et al. A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. J Infect Dis 1987; 156: 622-9.
16. 16. Zuccola HJ, Rozzelle JE, Lemon SM, et al. Structural basis of the oligomerization of hepatitis delta antigen. Structure 1998; 6: 821-30.
17. 17. Kos A, Dijkema R, Arnberg AC, et al. The hepatitis delta virus possesses a circular RNA. Nature 1986; 323: 558-60.
18. 18. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence, and expression of the hepatitis delta viral genome. Nature 1986; 323: 508-14.
19. 19. Makino S, Chang MF, Shieh CK, et al. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature 1987; 329: 343-6.
20. 20. Kuo MYP, Goldberg J, Coates L, et al. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure and applications. J Virol 1988; 62: 1855-61.
21. 21. Casey JL, Brown TL, Colan EJ, et al. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 1993; 90: 9016-20.
22. 22. Imazeki F, Omata M Ohio M. Complete nucleotide sequence of hepatitis delta virus RNA in Japan. Nucleic Acids Res 1991; 19: 5439.
23. 23. Wu JC, Choo KB, Chen CM, et al. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995; 346: 939-41.
24. 24. Wu JC, Chiang TY Sheen IJ. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol 1998; 79: 1105-13.
25. 25. Lee CM, Bih FY, Chao YC, et al. Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992; 188: 265-73.
26. 26. Imazeki F, Omata M Ohio M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 1990; 64: 5594-9.
27. 27. Chao YC, Chang MF, Gust I, et al. Sequence conservation and divergence of hepatitis delta virus RNA. Virology 1990; 178: 384-92.
28. 28. Chao YC, Lee CM, Tang HS, et al. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology 1991; 13: 345-52.
29. 29. Elena SF, Dopazo J, Flores R, et al. Phylogeny of viroids, viroidlike satellite RNAs, and the viroidlike domain of hepatitis delta virus RNA. Proc Natl Acad Sci USA 1991; 88: 5631-4.
30. 30. Brazas R, Ganem D. A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution. Science 1996; 274: 90-4.
31. 31. Long M, de Souza SJ Gilbert W. Delta-interacting protein A and the origin of hepatitis delta antigen. Science 1997; 276: 824-5.
32. 32. Robertson HD. How did replicating and coding RNAs first get together? Science 1996; 274: 66-7.
33. 33. Branch AD, Benenfeld BJ, Baroudy BM, et al. An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science 1989; 243: 649-52.
34. 34. Wu HN, Lai MMC. Reversible cleavage and ligation of hepatitis delta virus RNA. Science 1989; 243: 652-4.
35. 35. Wu HN, Lin YJ, Lin FP, et al. Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci USA 1989; 86: 1831-5.
36. 36. Kuo MYP, Sharmeen L, Dinter-Gottlieb G, et al. Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol 1988; 62: 4439-44.
37. 37. Sharmeen L, Kuo MYP, Dinter-Gottlieb G, et al. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol 1988; 62: 2674-9.
38. 38. Wu HN, Wang YJ, Hung CF, et al. Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol 1992; 223: 233-45.
39. 39. Branch AD, Robertson HD. Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent. Proc Natl Acad Sci USA 1991; 88: 10163-7.
40. 40. Perrotta AT, Been MD. Cleavage of oligoribonucleotides by a ribozyme derived from the hepatitis delta virus RNA sequence. Biochemistry 1992; 31: 16-21.
41. 41. Puttaraju M, Perrotta AT Been MD. A circular trans-acting hepatitis delta virus ribozyme. Nucleic Acids Res 1993; 21: 4253-8.
42. 42. Lazinski DW, Taylor JM. Intracellular cleavage and ligation of hepatitis delta virus genomic RNA: regulation of ribozyme activity by cis-acting sequences and host factors. J Virol 1995; 69: 1190-1200.
43. 43. Jeng KS, Su PY Lai MMC. Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol 1996; 70: 4205-9.
44. 44. Jeng KS, Daniel A Lai MMC. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol 1996; 70: 2403-10.
45. 45. Sharmeen L, Kuo MYP Taylor J. Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol 1989; 63: 1428-30.
46. 46. Forster AC, Symons RH. Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites. Cell 1987; 49: 211-20.
47. 47. Hampel A, Tritz R. RNA catalytic properties of the minimum (-)sTRSV sequence. Biochemistry 1989; 28: 4929-33.
48. 48. Perrotta AT, Been MD. Assessment of disparate structural features in three models of the hepatitis delta virus ribozyme. Nucleic Acids Res 1993; 21: 3959-65.
49. 49. Been MD. Cis-and trans-acting ribozymes from a human pathogen, hepatitis delta virus. Trends Biochem Sci 1994; 19: 251-6.
50. 50. Tanner NK, Schaff S, Thill G, et al. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses. Curr Biol 1994; 4: 488-98.
51. 51. Perrotta AT, Been MD. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature 1991; 350: 434-6.
52. 52. Ferre-D'Amare AR, Zhou K, Doudna JA. Crystal structure of a hepatitis delta virus ribozyme. Nature 1998; 395: 567-574.
53. 53. Perrotta AT, Been MD. The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucleic Acids Res 1990; 18: 6821-7.
54. 54. Pattnaik AK, Ball LA, LeGrone AW, et al. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell 1992; 69: 1011-20.
55. 55. Macnaughton TB, Wang YJ Lai MMC. Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol 1993; 67: 2228-34.
56. 56. Wu HN, Huang ZS. Mutagenesis analysis of the self-cleavage domain of hepatitis delta virus antigenomic RNA. Nucleic Acids Res 1992; 20: 5937-41.
57. 57. Chang MF, Baker SC, Soe LH, et al. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol 1988; 62: 2403-10.
58. 58. Roggendorf M, Pahlke C, Bohm B, et al. Characterization of proteins associated with hepatitis delta virus. J Gen Virol 1987; 68: 2953-9.
59. 59. Kuo MYP, Chao M Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol 1989; 63: 1945-50.
60. 60. Ryu WS, Bayer M Taylor J. Assembly of hepatitis delta virus particles. J Virol 1992; 66: 2310-5.
61. 61. Chang FL, Chen PJ, Tu SJ, et al. The large form of hepatitis δ antigen is crucial for assembly of hepatitis δ virus. Proc Natl Acad Sci USA 1991; 88: 8490-4.
62. 62. Glenn JS, White JM. Trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol 1991; 65: 2357-61.
63. 63. Chao M, Hsieh SY Taylor J. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol 1990; 64: 5066-9.
64. 64. Casey JL, Gerin JL. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 1995; 69: 7593-7600.
65. 65. Poison AG, Bass BL Casey JL. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996; 380: 454-6.
66. 66. Poison AG, Ley HL, Bass BL, et al. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol Cell Biol 1998; 18: 1919-26.
67. 67. Wang JG, Lemon SM. Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J Virol 1993; 67: 446-54.
68. 68. Chen PI, Chang FL, Wang CJ, et al. Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J Virol 1992; 66: 2853-9.
69. 69. Xia YP, Lai MMC. Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J Virol 1992; 66: 6641-8.
70. 70. Chang MF, Sun CY, Chen CJ, et al. Functional motifs of delta antigen essentiaJ for RNA binding and replication of hepatitis delta virus. J Virol 1993; 67: 2529-36.
71. 71. Xia YP, Yeh CT, Ou JH, et al. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol 1992; 66: 914-21.
72. 72. Chang MF, Chang SC, Chang CI, et al. Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol 1992; 66: 6019-27.
73. 73. Chou HC, Hsieh TY, Sheu GT, et al. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol 1998; 72: 3684-90.
74. 74. Lee CZ, Lin JH, Chao M, et al. RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol 1993; 67: 2221-7.
75. 75. Lazinski D, Grzadzielska E Das A. Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 1989; 59: 207-18.
76. 76. Wang HW, Chen PJ, Lee CZ, et al. Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: different roles for the small and large delta antigens. J Virol 1994; 68: 6363-71.
77. 77. Poisson F, Roingeard P Goudeau A. Direct investigation of protein RNA-binding domains using digoxigenin-labelled RNAs and synthetic peptides: application to the hepatitis delta antigen. J Virol Methods 1995; 55: 381-9.
78. 78. Poisson F, Roingeard P, Baillou A, et al. Characterization of RNA-binding domains of hepatitis delta antigen. J Gen Virol 1993; 74: 2473-8.
79. 79. Yeh TS, Lo SJ, Chen PJ, et al. Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly. J Virol 1996; 70: 6190-8.
80. 80. Cheng JW, Sin IJ, Lou YC, et al. Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigen. J Biomol NMR 1998; 12: 183-8.
81. 81. Huang ZS, Wu HN. Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. J Biol Chem 1998; 273: 26455-61.
82. 82. Lin JH, Chang MF, Baker SC, et al. Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol 1990; 64: 4051-8.
83. 83. Chao M, Hsieh SY Taylor J. The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol 1991; 65: 4057-62.
84. 84. Hwang SB, Lee CZ Lai MMC. Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 1992; 190: 413-22.
85. 85. Lazinski DW, Taylor JM. Relating structure to function in the hepatitis delta virus antigen. J Virol 1993; 67: 2672-80.
86. 86. Hwang SB, Jeng KS Lai MMC. Studies of functional roles of hepatitis delta antigen in delta virus RNA replication. In: Dinter-Gottlieb, G., ed. The unique hepatitis delta virus. Pp. 95-109. Austin: R. G. Landes Company, 1995.
87. 87. Hwang SB, Lai MMC. A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody. Virology 1993; 193: 924-31.
88. 88. Wei Y, Ganem D. Activation of heterologous gene expression by the large isoform of hepatitis delta antigen. J Virol 1998; 72: 2089-96.
89. 89. Lo K, Sheu GT Lai MMC. Inhibition of cellular RNA polymerase II transcription by delta antigen of hepatitis delta virus. Virology 1998; 247: 178-88.
90. 90. Otto JC, Casey PJ. The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells. J Biol Chem 1996; 271: 4569-72.
91. 91. Glenn JS, Watson JA, Havel CM, et al. Identification of a prenylation site in delta virus large antigen. Science 1992; 256: 1331-3.
92. 92. Lee CZ, Chen PJ, Lai MMC, et al. Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology 1994; 199: 169-75.
93. 93. Chang MF, Chen CJ Chang SC. Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus. J Virol 1994; 68: 646-53.
94. 94. Glenn JS, Marsters JC Greenberg HB. Use of a prenylation inhibitor as a novel antiviral agent. J Virol 1998; 72: 9303-6.
95. 95. Lee CZ, Chen PJ Chen DS. Large hepatitis delta antigen in packaging and replication inhibition: role of the carboxyl-terminal 19 amino acids and amino-terminal sequences. J Virol 1995; 69: 5332-6.
96. 96. de Bruin W, Leenders W, Kos T, et al. In vitro binding properties of the hepatitis delta antigens to the hepatitis B virus envelope proteins: potential significance for the formation of delta particles. Virus Res 1994; 31: 27-37.
97. 97. Hwang SB, Lai MMC. Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol 1993; 67: 7659-62.
98. 98. Hwang SB, Lai MMC. Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol 1994; 68: 2958-64.
99. 99. Casey JL, Gerin JL. Genotype-specific complementation of hepatitis delta virus RNA replication by hepatitis delta antigen. J Virol 1998; 72: 2806-14.
100. 100. Lazinski DW, Taylor JM. Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J Virol 1994; 68: 2879-88.
101. 101. Hsieh SY, Taylor JM. Regulation of polyadenylation of hepatitis delta virus antigenomic RNA. J Virol 1991; 65: 6438-46.
102. 102. Hsieh SY, Yang PY, Ou JT, et al. Polyadenylation of the mRNA of hepatitis delta virus is dependent upon the structure of the nascent RNA and regulated by the small or large delta antigen. Nucleic Acids Res 1994; 22: 391-6.
103. 103. Modahl LE, Lai MMC. Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV and replication. RNA transcription. J Virol 1998; 72: 5449-56.
104. 104. Sureau C, Jacob JR, Eichberg JW, et al. Tissue culture system for infection with human hepatitis delta virus. J Virol 1991; 65: 3443-50.
105. 105. Choi SS, Rasshofer R, Roggendorf M. Propagation of woodchuck hepatitis delta virus in primary woodchuck hepatocytes. Virology 1988; 167: 451-7.
106. 106. Taylor J, Mason W, Summers J, et al. Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol 1987; 61: 2891-5.
107. 107. Ponzetto A, Cote PJ, Popper H, et al. Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci USA 1984; 81: 2208-12.
108. 108. Macnaughton TB, Beard MR, Chao M, et al. Endogenous promoters can direct the transcription of hepatitis delta virus RNA from a recircularized cDNA template. Virology 1993; 196: 629-36.
109. 109. Tai FP, Chen PJ, Chang EL, et al. Hepatitis delta virus cDNA monomer can be used in transfection experiments to initiate viral RNA replication. Virology 1993; 197: 137-42.
110. 110. Wang HW, Wu HL, Chen DS, et al. Identification of the functional regions required for hepatitis D virus replication and transcription by linker-scanning mutagenesis of viral genome. Virology 1997; 239: 119-31.
111. 111. Glenn JS, Taylor JM White JM. In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol 1990; 64: 3104-7.
112. 112. Bichko V, Netter HJ Taylor J. Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. J Virol 1994; 68: 5247-52.
113. 113. Dingle K, Bichko V, Zuccola H, et al. Initiation of hepatitis delta virus genome replication. J Virol 1998; 72: 4783-8.
114. 114. Ponzetto A, Negro F, Popper H, et al. Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees. Hepatology 1988; 8: 1655-61.
115. 115. Rizzetto M, Canese MG, Gerin JL, et al. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980; 141: 590-602.
116. 116. Netter HJ, Kajino K Taylor JM. Experimental transmission of human hepatitis delta virus to the laboratory mouse. J Virol 1993; 67: 3357-62.
117. 117. Polo JM, Jeng KS, Lim B, et al. Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol 1995; 69: 4880-7.
118. 118. Polo JM, Lim B, Govindarajan S, et al. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J Virol 1995; 69: 5203-7.
119. 119. Macnaughton TB, Gowans EJ, McNamara SP, et al. Hepatitis 5 antigen is necessary for access of hepatitis δ virus RNA to the cell transcriptional machinery but is not part of the transcriptional complex. Virology 1991; 184: 387-90.
120. 120. Beard MR, MacNaughton TB Gowans EJ. Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. J Virol 1996; 70: 4986-95.
121. 121. Fu TB, Taylor J. The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol 1993; 67: 6965-72.
122. 122. Halpern MS, England JM, Deery DT, et al. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc Natl Acad Sci USA 1983; 80: 4865-9.
123. 123. Pasquinelli C, Laure F, Chatenoud L, et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 1986; 3: 95-103.
124. 124. Gowans EJ, Baroudy BM, Negro F, et al. Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology 1988; 167: 274-8.
125. 125. Macnaughton TB, Gowans EJ, Jilbert AR, et al. Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology 1990; 177: 692-8.
126. 126. Rackwitz HR, Rohde W Sanger HL. DNA-dependent RNA pol II of plant origin transcribes viroid RNA into full-length copies. Nature 1981; 291: 297-301.
127. 127. Branch AD, Robertson HD. A replication cycle for viroids and other small infectious RNA's. Science 1984; 223: 450-5.
128. 128. Chen PJ, Kalpana G, Goldberg J, et al. Structure and replication of the genome of hepatitis delta virus. Proc Natl Acad Sci USA 1986; 83: 8774-8.
129. 129. Hsieh SY, Chao M, Coates L, et al. Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol 1990; 64: 3192-8.
130. 130. Bichko VV, Khudyakov YE, Taylor JM. A novel form of hepatitis delta antigen. J Virol 1996; 70: 3248-51.
131. 131. Khudyakov YE, Makhov AM. Amino acid sequence similarity between the terminal protein of hepatitis B virus and predicted hepatitis delta virus gene product. FEBS Lett 1990; 262: 345-8.
132. 132. Khudyakov YE, Favorov MO Fields HA. A small open reading frame of the hepatitis delta virus antigenomic RNA encodes a protein that elicits antibodies in some infected patients. Virus Res 1993; 27: 13-24.
133. 133. Lai MMC. The molecular biology of hepatitis delta virus. Annu Rev Biochem 1995; 64: 259-86.
134. 134. Lo K, Hwang SB, Duncan R, et al. Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA. Virology 1998; 250: 94-105.
135. 135. Luo G, Chao M, Hsieh SY, et al. A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol 1990; 64: 1021-7.
136. 136. Casey JL, Bergmann KF, Brown TL, et al. Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci USA 1992; 89: 7149-53.
137. 137. Zheng H, Fu TB, Lazinski D, et al. Editing on the genomic RNA of human hepatitis delta virus. J Virol 1992; 66: 4693-7.
138. 138. Hourioux C, Sureau C, Poisson F, et al. Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains. J Gen Virol 1998; 79: 1115-9.
139. 139. Sureau C, Guerra B Lanford RE. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol 1993; 67: 366-72.
140. 140. Di Bisceglie AM, Negro F. Diagnosis of hepatitis delta virus infection. Hepatology 1989; 10: 1014-6.
141. 141. Recchia S, Rizzi R, Aquaviva F, et al. Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica 1981; 73: 773-7.
142. 142. Jardi R, Buti M, Rodriguez F, et al. Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgM. J Virol Methods 1994; 50: 59-66.
143. 143. Wu JC, Chen TZ, Huang YS, et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 1995; 108: 796-802.
144. 144. Tang JR, Cova L, Lamelin JP, et al. Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction. J Hepatol 1994; 21: 953-60.
145. 145. Simpson LH, Battegay M, Hoofnagle JH, et al. Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis. Dig Dis Sci 1994; 39: 2650-5.
146. 146. Jardi R, Buti M, Cotrina M, et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 1994; 21: 25-9.
147. 147. Dinolfo L, Abate ML, Bertolo P, et al. Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay. Int J Clin Lab Res 1995; 25: 35-9.
148. 148. Buti M, Esteban R, Jardi R, et al. Clinical and serological outcome of acute delta infection. J Hepatol 1987; 5: 59-64.
149. 149. Hepatitis Branch, Centers for Disease Control and Prevention. Epidemiology and prevention of viral hepatitis A to E: an overview. 1998. WWW URL: http://www.cdc.gov/ ncidod/diseases/hepatitis/slideset/httoc.htm.
150. 150. Smedile A, Verme G, Farci P, et al. Influence of delta infection on severity of hepatitis B. Lancet 1982; ii: 945-7.
151. 151. Tassopoulos NC, Koutelou MG, Macagno S, et al. Diagnostic significance of IgM antibody to hepatitis delta virus in fulminant hepatitis B. J Med Virol 1990; 30: 174-7.
152. 152. Govindarajan S, Chin KP, Redeker AG, et al. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984; 86: 1417-20.
153. 153. Moestrup T, Hansson BG, Widell A, et al. Clinical aspects of delta infection. Br Med J 1983; 286: 87-90.
154. 154. Caredda F, Antinori S, Re T, et al. Course and prognosis of acute HDV hepatitis. Prog Clin Biol Res 1987; 234: 267-76.
155. 155. Dimitrakakis M, Waters MJ, Wootton A, et al. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus. J Med Virol 1986; 20: 305-11.
156. 156. Aragona M, Caredda F, Lavarini C, et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1987; i: 478-80.
157. 157. Buti M, Esteban R, Roggendorf M, et al. Hepatitis δ virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis δ virus infection. Hepatology 1988; 8: 1125-9.
158. 158. Buti M, Esteban R, Jardi R, et al. Serological diagnosis of acute delta hepatitis. J Med Virol 1986; 18: 81-5.
159. 159. Negro F, Rizzetto M. Diagnosis of hepatitis delta virus infection. J Hepatol 1995; 22(Suppl 1): 136-9.
160. 160. Zignego AL, Deny P, Feray C, et al. Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning. Mol Cell Probes 1990; 4: 43-51.
161. 161. Polish LB, Gallagher M, Fields HA, et al. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993; 6: 211-29.
162. 162. Hoofnagle JH. Type D (delta) hepatitis. JAMA 1989; 1989: 261.
163. 163. Rizzetto M, Shih JWK Gerin JL. The hepatitis B virus-associated δantigen: isolation from liver, development of solid-phase radioimmunoassays for δantigen and anti-δ, and partial characterization of δantigen. J Immunol 1980; 125: 318-24.
164. 164. Melero M, Bartolome J, Peon A, et al. HDV RNA follow-up in HDV chronic infection. In: Gerin J, Purcell R Rizzetto, M, eds. The hepatitis delta virus. Pp. 41-50. New York: Wiley-Liss, 1991.
165. 165. Madejon A, Castillo I, Bartolome J, et al. Detection of HDV RNA in serum of patients with chronic HDV infection. J Hepatol 1990; 11: 381-4.
166. 166. Gaudin JL, Faure P, Godinot H, et al. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial. Liver 1995; 15: 45-52.
167. 167. Madejon A, Cotonat T, Bartolome J, et al. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-α2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology 1993; 19: 1331-6.
168. 168. Ottobrelli A, Marzano A, Smedile A, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991; 101: 1649-55.
169. 169. Samuel D, Zignego AL, Reynes M, et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 1994; 21: 333-9.
170. 170. Rizzetto M, Macagno S, Chiaberge E, et al. Liver transplantation in hepatitis delta virus disease. Lancet 1987; 2: 469-71.
171. 171. Negro F, Rizzetto M. Pathobiology of hepatitis delta virus. In: Hollinger F, Lemon S Margolis H, eds. Viral hepatitis and liver disease. Pp. 477-80. Baltimore: Williams & Wilkins Co., 1991.
172. 172. Smedile A, Casey JL, Cote PJ, et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 1998; 27: 1723-9.
173. 173. Morante AL, De La Cruz F, De Lope CR, et al. Hepatitis B virus replication in hepatitis B and D coinfection. Liver 1989; 9: 65-70.
174. 174. Caredda F, Antinori S, Pastecchia C, et al. Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis 1989; 159: 977-8.
175. 175. Wu JC, Lee SD, Govindarajan S, et al. Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study. J Infect Dis 1990; 161: 1116-20.
176. 176. Tassopoulos NC, Karayannis AR Papaevangelou GJ. Acute delta hepatitis and hepatitis B antigen carriage. Ann Intern Med 1986; 105: 804-5.
177. 177. Chin KP, Govindarajan S Redeker AG. Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection. Dig Dis Sci 1988; 33: 851-6.
178. 178. Krogsgaard K, Kryger P, Aldershvile J, et al. The Copenhagen hepatitis acut programme. δ-Infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology 1987; 7: 42-5.
179. 179. Hadziyannis SJ, Sherman M, Lieberman HM, et al. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology 1985; 5: 544-7.
180. 180. Govindarajan S, Valinluck B. Serum hepatitis B virus-DNA in chronic hepatitis B and delta infection. Arch Pathol Lab Med 1985; 109: 398-9.
181. 181. Wang JG, Jansen RW, Brown EA, et al. Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol 1990; 64: 1108-16.
182. 182. Poisson F, Baillou A, Dubois F, et al. Immune response to synthetic peptides of hepatitis delta antigen. J Clin Microbiol 1993; 31: 2343-9.
183. 183. Bergmann KF, Cote PJ, Moriarty A, et al. Hepatitis delta antigen: antigenic structure and humoral immune response. J Immunol 1989; 143: 3714-21.
184. 184. Nisini R, Paroli M, Accapezzato D, et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997; 71: 2241-51.
185. 185. Accapezzato D, Nisini R, Paroli M, et al. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis δantigen. J Immunol 1998; 160: 5262-6.
186. 186. Bichko VV, Lemon SM, Wang JG, et al. Epitopes exposed on hepatitis delta virus ribonucleoproteins. J Virol 1996; 70: 5807-11.
187. 187. Karayiannis P, Saldanha J, Monjardino J, et al. Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. Hepatology 1990; 12: 1125-8.
188. 188. Karayiannis P, Saldanha J, Jackson AM, et al. Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus. J Med Virol 1993; 41: 210-214.
189. 189. Chu CM, Liaw YF. Studies on the composition of the mononuclear cell infiltrates in liver from patients with chronic active delta hepatitis. Hepatology 1989; 10: 911-5.
190. 190. Franco A, Barnaba V, Natali PG, et al. Expression of class I and class II major histocompatibilty antigens on human hepatocytes. Hepatology 1988; 8: 449-54.
191. 191. Neefjes JJ, Mombourg F. Cell biology of antigen presentation. Curr Opin Immunol 1993; 5: 27-34.
192. 192. Sherman LA, Burke TA Biggs JA. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J Exp Med 1992; 175: 1221-6.
193. 193. Kozlowski S, Corr M, Takeshita T, et al. Serum angiotensin-1-converting enzyme activity processes a human immunodeficiency virus/gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med 1992; 175: 1417-22.
194. 194. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-99.
195. 195. Srassburg CP, Obermayer-Straub P Manns MP. Autoimmunity in hepatitis C and D virus infection. J Virol Hepat 1996; 3: 49-59.
196. 196. Manns MP. Hepatotropic viruses and autoimmunity 1997. J Viral Hepat 1997; 4(Suppl 1): 7-10.
197. 197. Manns MP, Obermayer-Straub P. Viral induction of autoimmunity: mechanisms and examples in hepatology. J Viral Hepat 1997; 4(Suppl 2): 42-7.
198. 198. Rosina F, Cozzolongo R. Interferon in HDV infection. Antiviral Res 1994; 24: 165-74.
199. 199. Colledan M, Gislon M, Doglia M, et al. Liver transplantation in patients with B viral hepatitis and delta infection. Transplant Proc 1987; 19: 4073-6.
200. 200. Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339: 61-8.
201. 201. Chen PJ, Wu HL, Wang CJ, et al. Molecular biology of hepatitis D virus: research and potential for application. J Gastroenterol Hepatol 1997; 12: S188-92.
202. 202. Chen TZ, Wu JC, Au LC, et al. Specific inhibition of delta antigen by in vitro system by antisense oligodeoxynucleotide: implications for translation mechanism and treatment. J Virol Methods 1997; 65: 183-9.
203. 203. Wu HL, Chen PJ, Mu JJ, et al. Assembly of hepatitis delta virus-like empty particles in yeast. Virology 1997; 236: 374-81.